{"log_id": 3515297685688940214, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.015027, "average": 0.936857, "min": 0.441498}, "location": {"width": 1120, "top": 379, "height": 36, "left": 313}, "words": "在初次接受治疗的受试者中,富马酸替诺福二呋酯治疗组在144周的治疗过程中,有847"}, {"probability": {"variance": 0.011698, "average": 0.945276, "min": 0.573351}, "location": {"width": 1131, "top": 413, "height": 41, "left": 299}, "words": "7)出现K65置换;其中7例发生在治疗的前铝8周,例发生在第96周,在以往接受过富马"}, {"probability": {"variance": 0.02198, "average": 0.897351, "min": 0.469471}, "location": {"width": 1166, "top": 448, "height": 43, "left": 258}, "words": "酸替诺福韦二吡呋能治疗的受试者中,14/304(5%)在90周之内治疗失败,其病毒株对林诺"}, {"probability": {"variance": 0.020199, "average": 0.930572, "min": 0.483781}, "location": {"width": 1175, "top": 484, "height": 41, "left": 258}, "words": "的敏感性下降超过1.4倍(中位值2.7倍)对产生耐药性的病毒株进行基因型分析,显示有日1V-1逆"}, {"probability": {"variance": 0.017152, "average": 0.934785, "min": 0.437927}, "location": {"width": 480, "top": 521, "height": 34, "left": 258}, "words": "转录酶基因置换,导致K5R氨基酸替代"}, {"probability": {"variance": 0.041158, "average": 0.783452, "min": 0.538688}, "location": {"width": 130, "top": 587, "height": 32, "left": 260}, "words": "交叉耐药性"}, {"probability": {"variance": 0.020013, "average": 0.904107, "min": 0.452113}, "location": {"width": 1122, "top": 653, "height": 43, "left": 306}, "words": "恩曲他滨和富马酸替诺福韦二世呋酯:目前已确认有些核苷逆转录酶抑制剂NRT1)之间会产生"}, {"probability": {"variance": 0.0247, "average": 0.892656, "min": 0.439181}, "location": {"width": 1161, "top": 688, "height": 43, "left": 253}, "words": "交叉耐药性。从细胞培养中筛选出恩曲伯滨和替诺福韦合用后发生M184V/和/或K65E胃换病毒株"}, {"probability": {"variance": 0.017502, "average": 0.93132, "min": 0.350221}, "location": {"width": 1175, "top": 724, "height": 41, "left": 253}, "words": "此类变异病毒株在替诺福韦与拉米夫定或恩曲他滨联合用药,以及替诺福与阿巴卡韦,去羟肌苷"}, {"probability": {"variance": 0.012522, "average": 0.958421, "min": 0.370173}, "location": {"width": 1177, "top": 759, "height": 43, "left": 253}, "words": "联台用药治疗失败的患者分离的病毒株中也有发现,因此,交叉药性可在携带含一个或两个此类"}, {"probability": {"variance": 0.02567, "average": 0.906398, "min": 0.492985}, "location": {"width": 411, "top": 797, "height": 29, "left": 278}, "words": "苴换)基因突变病毒的患者中产生"}, {"probability": {"variance": 0.017675, "average": 0.910853, "min": 0.573667}, "location": {"width": 1111, "top": 859, "height": 43, "left": 304}, "words": "恩曲他滨:恩由他滨耐药病毒株(M184V/L)对拉米大定和扎西他滨产生交叉耐药性,但其在"}, {"probability": {"variance": 0.009984, "average": 0.9364, "min": 0.515865}, "location": {"width": 1172, "top": 896, "height": 43, "left": 251}, "words": "细胞培养中对去羟肌苷、司他夫定、替诺福韦、齐多夫定,非核苷逆转录酶抑制剂(地拉韦定、依"}, {"probability": {"variance": 0.013579, "average": 0.937552, "min": 0.528711}, "location": {"width": 1175, "top": 932, "height": 43, "left": 246}, "words": "法韦伦,奈韦拉平)仍保持敏感性。接受阿巴卡韦、去羟苷、替诺福书和扎西他滨治疗的患者中"}, {"probability": {"variance": 0.018489, "average": 0.922536, "min": 0.432473}, "location": {"width": 1163, "top": 971, "height": 36, "left": 249}, "words": "分离出的含有5置换的HIV-1病毒株,其对恩曲他滨抑制作用的敏感性降低。对齐多夫定和司"}, {"probability": {"variance": 0.016214, "average": 0.899688, "min": 0.440351}, "location": {"width": 1175, "top": 1003, "height": 43, "left": 249}, "words": "他夫定(M41L、D67N、K70R,L210W,T215SY/FK219Q/E置换)和去羟肌苷(L74V置换)坡感性降"}, {"probability": {"variance": 0.012709, "average": 0.944627, "min": 0.373581}, "location": {"width": 1172, "top": 1037, "height": 45, "left": 249}, "words": "低的HV-1病毒仍保持对恩曲滨的敏感性:有与非核苷逆转录酶抑制剂耐药性相关的KI03N胃"}, {"probability": {"variance": 0.059702, "average": 0.835083, "min": 0.350838}, "location": {"width": 441, "top": 1074, "height": 38, "left": 246}, "words": "换的病毒株对曲滨仍敏感"}, {"probability": {"variance": 0.004392, "average": 0.962387, "min": 0.752097}, "location": {"width": 1115, "top": 1140, "height": 43, "left": 297}, "words": "富马酸替诺福韦二吡酯:从20例受试者中分离出的平均带有3种与齐多夫定相关的逆转录"}, {"probability": {"variance": 0.019207, "average": 0.889703, "min": 0.449288}, "location": {"width": 1175, "top": 1175, "height": 45, "left": 244}, "words": "酶氨基酸置换(MI1.D7N、K70R、L210W、T215Y/F或K2190/E/N)的HIV-1病毒株对替诺福书的敏"}, {"probability": {"variance": 0.026455, "average": 0.91665, "min": 0.394842}, "location": {"width": 1177, "top": 1214, "height": 36, "left": 242}, "words": "感性下降了3.1倍产生L74V置换但无齐多夫定耐药性相关置换的受试者(N8)对富马酸替"}, {"probability": {"variance": 0.02964, "average": 0.894352, "min": 0.383907}, "location": {"width": 1154, "top": 1246, "height": 48, "left": 240}, "words": "诺福韦二呋酯的疗效反应降低。有限资料显示,含有15F置换(N=3)、Q15IM置换(N=2"}, {"probability": {"variance": 0.018209, "average": 0.917865, "min": 0.55067}, "location": {"width": 569, "top": 1284, "height": 34, "left": 240}, "words": "或T69插入(N=4)的患者疗效反应均降低"}, {"probability": {"variance": 1.9e-05, "average": 0.995552, "min": 0.988488}, "location": {"width": 109, "top": 1351, "height": 32, "left": 242}, "words": "毒理研究"}, {"probability": {"variance": 0.000593, "average": 0.95982, "min": 0.920323}, "location": {"width": 128, "top": 1417, "height": 34, "left": 240}, "words": "恩曲他滨:"}, {"probability": {"variance": 0.018541, "average": 0.90513, "min": 0.412133}, "location": {"width": 946, "top": 1483, "height": 38, "left": 294}, "words": "遗传性恩曲滨Anes试验、小鼠淋已式验、小微核试验结果均为阴性"}, {"probability": {"variance": 0.029582, "average": 0.895183, "min": 0.356278}, "location": {"width": 1134, "top": 1545, "height": 48, "left": 276}, "words": "学性维线子曲他滨人推看剂量200mg/日的约140倍暴露量,或雄/雌性小鼠给"}, {"probability": {"variance": 0.027883, "average": 0.904805, "min": 0.370414}, "location": {"width": 1172, "top": 1582, "height": 50, "left": 237}, "words": "予排荐剂量的6量时,对生育力未见影响。胚胎胎仔毒性试验中,小、家兔分别给"}, {"probability": {"variance": 0.030338, "average": 0.888233, "min": 0.405409}, "location": {"width": 1168, "top": 1618, "height": 48, "left": 237}, "words": "子人排剂量的约6C倍的暴露量(AUC)时,未见胎仔异常和畸形的发生率升高子代小"}, {"probability": {"variance": 0.015818, "average": 0.894051, "min": 0.499032}, "location": {"width": 1166, "top": 1653, "height": 48, "left": 235}, "words": "鼠从出生前(胎仔)到性成熟期间每日给予人推荐量(20mg/日)的约B0倍暴量(AUC),小"}, {"probability": {"variance": 0, "average": 0.991881, "min": 0.991881}, "location": {"width": 29, "top": 1691, "height": 32, "left": 233}, "words": "鼠"}, {"probability": {"variance": 0.068945, "average": 0.750438, "min": 0.395612}, "location": {"width": 157, "top": 1694, "height": 29, "left": 349}, "words": "力正常,"}, {"probability": {"variance": 0.019049, "average": 0.928562, "min": 0.404855}, "location": {"width": 1136, "top": 1755, "height": 48, "left": 272}, "words": "致性:恩曲经团给药的长期致性试验,小鼠给药剂量达750mg/kg/天(相当于治疗剂"}, {"probability": {"variance": 0.018933, "average": 0.923043, "min": 0.4718}, "location": {"width": 1166, "top": 1785, "height": 54, "left": 233}, "words": "量200吨天下身录量的28倍)或大鼠给药剂量达600mg/g/天(相当于治疗剂量下的人"}, {"probability": {"variance": 0.004499, "average": 0.974753, "min": 0.65237}, "location": {"width": 711, "top": 1826, "height": 43, "left": 233}, "words": "全身暴露量的31倍)时夫发现与药物相关的肿发生率升高"}], "language": 3}